What is the address of Placebo?

The registered office of Placebo is located at Vroonbaan 40, 1880 Kapelle-op-den-Bos.

Is Placebo still active?

Yes. According to the CBE (30 October 2026) Placebo is active, legal situation “Normale toestand”, started on 9 December 1981.

Is Placebo registered on Peppol?

Yes, Placebo is registered on the Peppol network with ID 0208:0422239119.

What is the enterprise number of Placebo?

The enterprise number of Placebo is BE0422239119.

When was Placebo founded?

Placebo was founded on 9 December 1981.

Who are the directors of Placebo?

According to the 2024 annual accounts, the directors of Placebo are: Godelieve Verhelst.

Is Placebo a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 December 1981; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Placebo make in 2024?

Placebo posted a profit after taxes of € 91,420 in financial year 2024.

What is the revenue of Placebo?

As a small company, Placebo is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 242,226.

Placebo (Public Limited) - Kapelle-op-den-Bos

Dossier Placebo, printed on 30 October 2026 from databakkes.be/en/0422239119/placebo. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 8 % of short-term debt in 2024; threshold 65 %.

Financials

Financial year 2024

Placebo from Kapelle-op-den-Bos, company number BE0422239119, closed financial year 2024 with a result of € 91,420 after tax. For that financial year Placebo recorded a gross margin of € 242,226 and equity of € 667,787. Compared with financial year 2023, the result moved from € 27,986 to € 91,420. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.

What it is worth Growing

€ 667,787

▲ 16% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 91,420

▲ 227% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 21,239

▲ 297% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 171,787.

People and assets in 2024

Vehicles and equipment

€ 469

▼ 35% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 322,798

▼ 24% vs 2023

€ 83,750 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 86,598

▲ 22% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 17,398

▲ € 16,235 vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 146,964 Gross margin 2021: € 146,964 First fiscal year in the series	€ 99,660 Gross margin 2022: € 99,660 ▼ 32% vs 2021 (€ 146,964) Unfavourable step	€ 127,671 Gross margin 2023: € 127,671 ▲ 28% vs 2022 (€ 99,660) Favourable step	€ 242,226 Gross margin 2024: € 242,226 ▲ 90% vs 2023 (€ 127,671) Favourable step	▲ 90%
Profit after taxes	€ 61,088 Profit after taxes 2021: € 61,088 First fiscal year in the series	€ -8,210 Profit after taxes 2022: € -8,210 ▼ € 69,299 vs 2021 (€ 61,088) Unfavourable step	€ 27,986 Profit after taxes 2023: € 27,986 ▲ € 36,196 vs 2022 (€ -8,210) Favourable step	€ 91,420 Profit after taxes 2024: € 91,420 ▲ 227% vs 2023 (€ 27,986) Favourable step	▲ 227%
Equity	€ 556,591 Equity 2021: € 556,591 First fiscal year in the series	€ 548,381 Equity 2022: € 548,381 ▼ 1% vs 2021 (€ 556,591) Unfavourable step	€ 576,367 Equity 2023: € 576,367 ▲ 5% vs 2022 (€ 548,381) Favourable step	€ 667,787 Equity 2024: € 667,787 ▲ 16% vs 2023 (€ 576,367) Favourable step	▲ 16%
Total debts	€ 1,357,076 Total debts 2021: € 1,357,076 First fiscal year in the series	€ 1,390,781 Total debts 2022: € 1,390,781 ▲ 2% vs 2021 (€ 1,357,076) Unfavourable step	€ 1,357,537 Total debts 2023: € 1,357,537 ▼ 2% vs 2022 (€ 1,390,781) Favourable step	€ 1,269,785 Total debts 2024: € 1,269,785 ▼ 6% vs 2023 (€ 1,357,537) Favourable step	▼ 6%
Cash	€ 578 Cash 2021: € 578 First fiscal year in the series	€ 2,113 Cash 2022: € 2,113 ▲ 265% vs 2021 (€ 578) Favourable step	€ 5,346 Cash 2023: € 5,346 ▲ 153% vs 2022 (€ 2,113) Favourable step	€ 21,239 Cash 2024: € 21,239 ▲ 297% vs 2023 (€ 5,346) Favourable step	▲ 297%
Land & buildings	€ 1,924,409 Land & buildings 2021: € 1,924,409 First fiscal year in the series	€ 1,918,587 Land & buildings 2022: € 1,918,587 Unchanged (€ 1,924,409) Unchanged	€ 1,888,757 Land & buildings 2023: € 1,888,757 ▼ 2% vs 2022 (€ 1,918,587) Unchanged	€ 1,905,604 Land & buildings 2024: € 1,905,604 ▲ 1% vs 2023 (€ 1,888,757) Unchanged	▲ 1%
Retained profit	€ 60,591 Retained profit 2021: € 60,591 First fiscal year in the series	€ 52,381 Retained profit 2022: € 52,381 ▼ 14% vs 2021 (€ 60,591) Unfavourable step	€ 80,367 Retained profit 2023: € 80,367 ▲ 53% vs 2022 (€ 52,381) Favourable step	€ 171,787 Retained profit 2024: € 171,787 ▲ 114% vs 2023 (€ 80,367) Favourable step	▲ 114%
Bank debt	€ 575,343 Bank debt 2021: € 575,343 First fiscal year in the series	€ 499,666 Bank debt 2022: € 499,666 ▼ 13% vs 2021 (€ 575,343) Favourable step	€ 425,819 Bank debt 2023: € 425,819 ▼ 15% vs 2022 (€ 499,666) Favourable step	€ 322,798 Bank debt 2024: € 322,798 ▼ 24% vs 2023 (€ 425,819) Favourable step	▼ 24%
Balance sheet total	€ 1,956,823 Balance sheet total 2021: € 1,956,823 First fiscal year in the series	€ 1,980,358 Balance sheet total 2022: € 1,980,358 ▲ 1% vs 2021 (€ 1,956,823) Unchanged	€ 1,973,154 Balance sheet total 2023: € 1,973,154 Unchanged (€ 1,980,358) Unchanged	€ 1,998,344 Balance sheet total 2024: € 1,998,344 ▲ 1% vs 2023 (€ 1,973,154) Unchanged	▲ 1%

Key figures of Placebo, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Placebo?

What happened at Placebo in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2025 New annual accounts for financial year 2024: profit of € 91,420 (▲ 227% vs 2023). filed late Source: NBB ↗
2025 Godelieve Verhelst stepped down as director. NBB
2019 Godelieve Verhelst became a director. NBB
Jan 1, 1982 New establishment in Kapelle-op-den-Bos. KBO
Dec 9, 1981 Start of the company according to the CBE. KBO

In short

From € 61,088 profit in 2021 to € 91,420 profit in 2024.

Paid € 18,137 in corporate taxes since 2021.

Best year ever: 2024, with € 91,420 profit.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2024 annual accounts

Godelieve Verhelst

Director

Also active at: NIROY

since 2019 · until 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Vroonbaan 40

1880 Kapelle-op-den-Bos

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

NIROY same network

€ 12,159 gross margin · 2024

Petanqueclub Nikaro

SAZLIK LOGISTICS

€ 29,016 gross margin · 2025

DEN LOGISTICS

€ 144,707 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0422.239.119
VAT number: BE 0422.239.119
Registered office: Vroonbaan 40, 1880 Kapelle-op-den-Bos
Names & denominations: Placebo
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 9 December 1981
Peppol: Active · Active since 21 Oct 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

Placebo